National Institute on AgingAlzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association, vol.8, p.3266529, 2012. ,
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, vol.7, p.3220946, 2011. ,
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease, Annals of neurology, vol.71, issue.6, p.22488240, 2012. ,
, , p.3586223
Suspected non-Alzheimer disease pathophysiology-concept and controversy, Nature reviews Neurology, vol.12, issue.2, p.4784257, 2016. ,
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression, Neurology, vol.84, issue.5, p.25568301, 2015. ,
, , p.4336071
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease, Neurology, vol.80, issue.11, p.23390179, 2013. ,
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage, Brain: a journal of neurology, vol.138, p.5013930, 2015. ,
The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report, Journal of Alzheimer's disease: JAD, vol.60, issue.2, p.28826178, 2017. ,
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers, Neurology, vol.87, issue.5, p.4970664, 2016. ,
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study, Lancet Neurol, vol.15, issue.10, p.27450471, 2016. ,
Longitudinal beta-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology, JAMA neurology, vol.73, issue.10, p.5237381, 2016. ,
Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals, JAMA neurology, vol.73, issue.10, p.5266522, 2016. ,
The nonlinear relationship between cerebrospinal fluid Abeta42 and tau in preclinical Alzheimer's disease, PloS one, vol.13, issue.2, p.5802432, 2018. ,
Impact of cerebrospinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study, Journal of neurology, vol.261, issue.1, p.24162039, 2014. ,
Who needs cerebrospinal biomarkers? A national survey in clinical practice, Journal of Alzheimer's disease: JAD, vol.40, issue.4, p.24577469, 2014. ,
Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders, p.29966201, 2018. ,
CSF level of ?-amyloid peptide predicts mortality in Alzheimer's disease, vol.11, p.30922415, 2019. ,
CSF biomarker variability in the Alzheimer's Association quality control program, vol.9, p.3707386, 2013. ,
Alzheimer's & dementia: the journal of the Alzheimer's Association, vol.14, p.5958625, 2018. ,
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting, vol.9, p.23141384, 2013. ,
Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations, Journal of pharmacokinetics and biopharmaceutics, vol.6, issue.2, pp.165-75, 1978. ,
Clearance systems in the brain-implications for Alzheimer disease, Nature reviews Neurology, vol.11, issue.8, p.4694579, 2015. ,
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England journal of medicine, vol.367, p.3474597, 2012. ,
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease, Science translational medicine, vol.6, issue.226, p.24598588, 2014. ,
, , p.4038930
Increased CSF Abeta during the very early phase of cerebral Abeta deposition in mouse models, EMBO molecular medicine, vol.7, issue.7, p.25978969, 2015. ,
, , p.4520655
Primary agerelated tauopathy (PART): a common pathology associated with human aging, Acta neuropathologica, vol.128, issue.6, pp.755-66, 2014. ,
, , p.4257842
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease, Acta neuropathologica, vol.129, issue.5, p.4534004, 2015. ,
PART is part of Alzheimer disease, Acta neuropathologica, vol.129, issue.5, p.4405349, 2015. ,
Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a oneyear autopsy population from a geriatric hospital, Cerebral cortex, vol.4, issue.2, pp.138-50, 1991. ,
The natural history of Alzheimer neurofibrillary tangles and amyloid deposits, Neurobiology of aging, vol.18, issue.4, p.9330968, 1997. ,
Alzheimer-type lesions in cognitively normal subjects, Neurobiology of aging, vol.62, p.5743763, 2018. ,